Tineke B.
- Country
- The Netherlands
- Department
- Department of Oncology
Research Overview
- Phase 3 Randomized Study of Adagrasib and Cetuximab Versus Chemotherapy in Advanced Colorectal Cancer with KRAS G12C Mutation Post-First-Line Therapy
- Randomized Controlled Trial of Induction Chemotherapy with Irinotecan, Folinic Acid, and Oxaliplatin Followed by Chemoradiotherapy for Locally Recurrent Rectal Cancer
- Phase 3 Randomized Trial of Nivolumab, Nivolumab with Ipilimumab, or Chemotherapy in MSI-H/dMMR Metastatic Colorectal Cancer
Data & Insights
Has run more than one trial at 70 of 187 partner sites.
Specializations
Oncology Focus
Specializes in the treatment of advanced colorectal cancer, with particular emphasis on cases involving KRAS G12C mutations.
- Colorectal Cancer Management
- Targeted Therapy Approaches
- Mutation-Specific Treatments
Active in evaluating innovative therapeutic combinations for treating gastrointestinal malignancies.
Precision Medicine
Focuses on developing personalized treatment strategies based on specific genetic mutations and molecular markers in cancer patients.
- Molecular Profiling
- Biomarker Analysis
- Targeted Therapeutics
Investigates novel therapeutic approaches in molecularly defined patient populations.
Therapeutic Innovation
Explores combination treatment strategies involving targeted therapies and established treatments for advanced cancer care.
- Combination Therapies
- Treatment Optimization
- Second-line Therapy
Studies innovative therapeutic combinations to improve patient outcomes in advanced disease settings.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.